Janssen Products LP v. Cipla Ltd.
1:15-cv-00307
Overview
Case Number
1:15-cv-00307
Filing Date
2015-04-10
Status
Litigation filed
Court
ded
Nature of Suit
830 Patent
Parties
Defendant
Plaintiff
Janssen Sciences Ireland UC
Represented By
3 Attorneys ListedAshby & Geddes
Tel: +1 (302) 654-1888
Ashby & Geddes, 500 Delaware Avenue, 8th Floor
Ashby & Geddes
Tel: +1 (302) 654-1888
Ashby & Geddes, 500 Delaware Avenue, 8th Floor
Ashby & Geddes
Tel: +1 (302) 654-1888
Fax: +1 (302) 654-2067
Ashby & Geddes, 500 Delaware Avenue, 8th Floor
Janssen Products LP
Represented By
3 Attorneys ListedAshby & Geddes
Tel: +1 (302) 654-1888
Ashby & Geddes, 500 Delaware Avenue, 8th Floor
Ashby & Geddes
Tel: +1 (302) 654-1888
Ashby & Geddes, 500 Delaware Avenue, 8th Floor
Ashby & Geddes
Tel: +1 (302) 654-1888
Fax: +1 (302) 654-2067
Ashby & Geddes, 500 Delaware Avenue, 8th Floor
Court & Judges
Court
ded
Patents Involved
No asserted patent numbers detected in initial docket filings yet.
Docket Entries
COMPLAINT filed against Cipla Ltd., Cipla USA Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1706071.) - filed by Janssen Products LP, Janssen Sciences Ireland UC. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Civil Cover Sheet)(aah) (Entered: 04/13/2015)
2015-04-10
1
Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (aah) (Entered: 04/13/2015)
2015-04-10
1
Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: March 2, 2015. Date of Expiration of Patent: December 26, 2026.Thirty Month Stay Deadline: 9/2/2017. (aah) (Entered: 04/13/2015)
2015-04-10
1
Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: March 2, 2015. Date of Expiration of Patent: February 16, 2024.Thirty Month Stay Deadline: 9/2/2017. (aah) (Entered: 04/13/2015)
2015-04-10
1